Skip to main content

Dasatinib

Meaning

Dasatinib is a potent, small-molecule drug classified as an oral tyrosine kinase inhibitor (TKI) primarily used in the therapeutic management of certain hematological malignancies, specifically Philadelphia chromosome-positive chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Its mechanism of action involves selectively blocking the activity of multiple key tyrosine kinases, thereby interfering with the aberrant signaling pathways that drive uncontrolled proliferation in cancer cells. While its primary role is oncological, its systemic effects necessitate careful clinical monitoring in patients, as it can indirectly influence metabolic and cardiovascular parameters. The development of Dasatinib exemplifies the precision and specificity of modern targeted cancer therapeutics.